1540P Ripretinib as ≥4th-line treatment in patients with advanced gastrointestinal stromal tumor: Long-term update from the phase III INVICTUS study

Authors:
  • MMM. von Mehren
    M. von Mehren
  • MHM.C. Heinrich
    M.C. Heinrich
  • SGS. George
    S. George
  • JZJ.R. Zalcberg
    J.R. Zalcberg
  • SBS. Bauer
    S. Bauer
  • HGH. Gelderblom
    H. Gelderblom
  • PSP. Schöffski
    P. Schöffski
  • CSC. Serrano
    C. Serrano
  • SAS. Attia
    S. Attia
  • GDG. D'AMato
    G. D'AMato
  • PCP. Chi
    P. Chi
Publisher website
Google Scholar
Abstract
No abstract available